Activation of adenosine A2B receptor impairs properties of trophoblast cells and involves mitogen-activated protein (MAP) kinase signaling
Activation of adenosine A2B receptor impairs properties of trophoblast cells and involves mitogen-activated protein (MAP) kinase signaling
复制标题
DOI:
10.1016/j.placenta.2014.06.369
复制
发表时间:
2014-09-01
期刊:
影响因子:
3.8
通讯作者:
von Versen-Hoeynck, F.
中科院分区:
文献类型:
--
作者:
Darashchonak, N.;Sarisin, A.;von Versen-Hoeynck, F.
Introduction: Shallow trophoblast invasion of the maternal spiral arteries contributes to impaired placental perfusion and is hypothesized to be involved in the pathophysiology of preeclampsia. Hypoxia is a potent stimulus for the release of adenosine.Methods: We investigated the effects of hypoxia and A(2B) adenosine receptor signaling on migration, invasion, proteolytic activity of matrix metalloproteinase (MMP)-2, expression of MMP-2 and vascular endothelial growth factor (VEGF) mRNA, and production of human chorionic gonadotropin (hCG) in trophoblast cells (HTR-8/SVneo, BeWo).Results: The adenosine A(2B) receptor agonist 5-N-ethylcarboxamidoadenosine (NECA) reduced trophoblast (HTR-8/SVneo and BeWo) migration at 2%, 8% and 21% O-2 compared to untreated control cells. A(2B) adenosine receptor stimulation decreased phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and stress-activated protein kinase/Jun-amino-terminal kinase (SAPK/JNK) at all three O-2 concentrations. ProMMP-2 activity, MMP-2 mRNA levels and hCG levels were markedly decreased after A(2B) adenosine receptor activation in trophoblast cells. Adenosine receptor A(2B) stimulation decreased VEGF expression at 2% and 8% O-2 but led to increased levels at 21% O-2.Conclusions: These data indicate A(2B) receptor activation blunts trophoblast migration possibly as a result of reduced activation of the MAPK signaling pathway and lower proMMP-2 levels. These data suggest a role for adenosine receptor An in placental development and possibly in the pathophysiology of preeclampsia. (C) 2014 Elsevier Ltd. All rights reserved.